Form 13-F position report

AVALO THERAPEUTICS INC COM PAR

Reported by Parallel Advisors LLC

AVTX CUSIP 05338F306 Manager CIK 0001690010

Reported 1 shares, unchanged from the prior quarter.

Reported value -16.7%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q3 2026
Shares 1 Quarter-end amount reported
Reported value $15 Fair value at quarter end
Consecutive quarters held 11 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-03-31 22
2024-06-30 12
2024-09-30 10
2024-12-31 7
2025-03-31 8
2025-06-30 5
2025-09-30 13
2025-12-31 18
2026-03-31 15
2026-06-30 18
2026-09-30 15

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for AVALO THERAPEUTICS INC COM PAR held by Parallel Advisors LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 1 0 (0.0%) < 0.01% $15 2026-11-03
Q2 2026 Unchanged 1 0 (0.0%) < 0.01% $18 2026-08-05
Q1 2026 Unchanged 1 0 (0.0%) < 0.01% $15 2026-05-07
Q4 2025 Unchanged 1 0 (0.0%) < 0.01% $18 2026-02-11
Q3 2025 Unchanged 1 0 (0.0%) < 0.01% $13 2025-11-13
Q2 2025 Unchanged 1 0 (0.0%) < 0.01% $5 2025-07-08
Q1 2025 Unchanged 1 0 (0.0%) < 0.01% $8 2025-04-08
Q4 2024 Unchanged 1 0 (0.0%) < 0.01% $7 2025-02-10
Q3 2024 Unchanged 1 0 (0.0%) < 0.01% $10 2024-11-13
Q2 2024 Unchanged 1 0 (0.0%) < 0.01% $12 2024-08-08
Q1 2024 New 1 +1 (0.0%) < 0.01% $22 2024-05-06

Who else reported the position

161 managers reported AVALO THERAPEUTICS INC COM PAR for Q3 2026.

Managers reporting AVALO THERAPEUTICS INC COM PAR in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 5,250,181 +149,965 < 0.01% $80,485,275 4 qtrs
BlackRock Inc Added 4,959,604 +594,051 < 0.01% $76,030,730 9 qtrs
FARALLON CAPITAL MANAGEMENT LLC Added 3,974,000 +1,476,000 0.26% $60,921,420 3 qtrs
Deep Track Capital LP Unchanged 3,610,000 0 0.9% $55,341,300 2 qtrs
Caligan Partners LP Added 3,268,303 +104,437 3.07% $50,103,085 5 qtrs
Affinity Asset Advisors LLC Added 3,244,861 +344,861 2.02% $49,743,719 11 qtrs
TCG Crossover Management LLC Unchanged 3,017,120 0 1.31% $46,252,450 9 qtrs
STATE STREET CORPORATION Reduced 2,563,226 -326,061 < 0.01% $39,294,255 5 qtrs
Avoro Capital Advisors LLC Added 2,377,777 +44,444 0.38% $36,451,321 3 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 2,256,245 -8,001 < 0.01% $34,588,236 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 03, 2026
Filing type
13F-HR
Position type
Stock

Voting authority reported

Sole
0
Shared
0
None
1

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.